Pioneering Next-Generation Sequencing in Kenya
The Center for Malaria Elimination at Mount Kenya University proudly announces the acquisition
of the Illumina NextSeq 1000, the first next-generation sequencer housed at an educational institution
in Kenya. This cutting-edge, high throughput platform places us at the forefront of genomic research,
uniquely equipped to tackle critical health challenges. With plans to use the sequencer for cancer research, antimicrobial resistance (AMR) studies, and the investigation of infectious tropical diseases, our
center underscores its commitment to transformative research. As the only university in Kenya with
such advanced capabilities, we prioritize impactful research while fostering collaborations across
disciplines and institutions, unlocking infinite possibilities for innovation and scientific discovery.
